News

ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING

Adaptilens Announces $17.5M in Series A Financing

April 29, 2024

We are thrilled to announce that Adaptilens has secured $17.5 million in Series A financing, led by Xontogeny and Perceptive Xontogeny Venture Fund, with participation

Adaptilens Featured in C&EN: Celebrating Founder-Led Biotech Innovation

November 13, 2024

Adaptilens Announces $17.5M in Series A Financing

April 29, 2024

Dr. Clamen featured in the When Science Speaks podcast

October 22, 2022

Dr. Clamen featured in the Amazing Execs episode 102 “Developing a Breakthrough New Ophthalmic Medical Device”

July 26, 2022

Adaptilens won a $75,000 Grand Prize award at the Harvard Innovation Lab’s President’s Innovation Challenge

May 3, 2022

Adaptilens chosen to participate in Harvard’s highly selective Launch Lab X GEO accelerator

October 25, 2021

Dr. Clamen receives the 2021 Massachusetts Next Generation award

June 14, 2021

Polymeric Materials for Eye Surface and Intraocular Applications

January 6, 2021

Announcing $1.6 million in seed funding led by Pillar VC additional participation from Accanto Partners

November 12, 2020

Adaptilens selected as a finalist for the 2020 MassChallenge Boston program

June 3, 2020

Updates

No updates found.

Adaptilens is made possible with help from

notice: The Adaptilens is in the development phase and is not yet approved for investigational or commercial use.

Follow our progress on